Breast Tissue Expanders

Breast Tissue Expander Options

AlloX2^®

Revolutionary dual-port design and integral drain allow for less invasive – non-surgical – draining of serous fluid

• Designed to mitigate key risks associated with breast
expansion and ultimately reduce reoperation rates

• Only tissue expander with an integral drain providing direct
access to the periprosthetic space where fluid can accumulate

• Allows for diagnostic fluid sampling to enable a faster
treatment response

“The unique feature of the AlloX2 provides surgeons easy access to the periprosthetic space without altering any of the other characteristics of a tissue expander. While one does not plan to experience a postoperative complication, a valid question in light of the availability of the AlloX2 is why one would forego utilizing a device that facilitates treatment thereof.”
Arash Momeni, MD
Board-Certified Plastic and Reconstructive Surgeon
Palo Alto Medical Center

Dermaspan^TM

Soft, refined design allows for
gentle and more comfortable expansion

• Soft, pliable shell results in less friction upon insertion

• Designed without ridges or rings for improved comfort

• Port location is designed to aid in predictable,
consistent expansion

Managing the risks of post-operative fluid accumulation

Obesity (BMI >30) and use of an Acellular Dermal Matrix (ADM) have been identified as major risk factors for seroma⁴

~40% of adult patients in the US are obese⁵
An ADM is used in over 60% of breast reconstruction cases⁶

A seroma increases the risk of major infection in breast reconstruction patients

Risk of infection is 4x higher in patients who develop a seroma⁴
Risk of expander loss caused by infection is 6.7x higher in patients who develop a seroma⁴

Clinically relevant infections with poor salvage rates occurred in nearly 1/5 of seroma patients (18.8%)⁴

78% of infections
require explantation⁴

Re-operation costs can run upwards of +$20K,⁷ which may not be covered by insurance if within 30 days of initial surgery⁸

Clinical Outcomes

AlloX2 improves salvage rates & clinical outcomes¹⁰

Retrospective review of 112 consecutive patients

63 patients (53.6%) Mentor Artoura

49 patients (43.7%) AlloX2

173 breasts with smooth tissue expanders (2016-2017)

AlloX2 Stats:

8% seroma rate
All successfully drained in clinic through AlloX²

100% Surgeon Satisfaction using AlloX2¹¹

In a clinical study with 40 primary reconstructive patients, the AlloX2 was deemed successful in treating seromas and should be considered a tool for noninvasive treatment of common complications of tissue expander-based breast reconstruction.

AlloX2®